Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 1
1979 1
1986 1
1988 1
1989 1
1991 3
1993 2
1996 1
1997 1
1998 2
2000 1
2002 2
2011 5
2012 6
2013 3
2014 3
2015 6
2016 5
2017 2
2018 4
2019 4
2020 2
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

48 results

Results by year

Filters applied: . Clear all
Page 1
[Lung cancer screening: Update, news and perspectives].
Wang P, Chapron J, Bennani S, Revel MP, Wislez M. Wang P, et al. Among authors: chapron j. Bull Cancer. 2023 Jan;110(1):42-54. doi: 10.1016/j.bulcan.2022.11.006. Epub 2022 Dec 7. Bull Cancer. 2023. PMID: 36496261 Review. French.
[IHC, FISH, CISH, NGS in non-small cell lung cancer: What changes in the biomarker era?].
Hamard C, Mignard X, Pecuchet N, Mathiot N, Blons H, Laurent-Puig P, Leroy K, Lupo A, Chapron J, Giraud F, Arrondeau J, Goldwasser F, Alifano M, Damotte D, Wislez M. Hamard C, et al. Among authors: chapron j. Rev Pneumol Clin. 2018 Oct;74(5):327-338. doi: 10.1016/j.pneumo.2018.09.013. Epub 2018 Oct 19. Rev Pneumol Clin. 2018. PMID: 30343945 Review. French.
The Schwann cell at the neuromuscular junction.
Koenig J, de La Porte S, Chapron J. Koenig J, et al. Among authors: chapron j. J Physiol Paris. 1998 Jun-Aug;92(3-4):153-5. doi: 10.1016/s0928-4257(98)80001-6. J Physiol Paris. 1998. PMID: 9789799 Review.
Is there an Exposure-Response Relationship for Nivolumab in Real-World NSCLC Patients?
Bellesoeur A, Ollier E, Allard M, Hirsch L, Boudou-Rouquette P, Arrondeau J, Thomas-Schoemann A, Tiako M, Khoudour N, Chapron J, Giraud F, Wislez M, Damotte D, Lupo A, Vidal M, Alexandre J, Goldwasser F, Tod M, Blanchet B. Bellesoeur A, et al. Among authors: chapron j. Cancers (Basel). 2019 Nov 13;11(11):1784. doi: 10.3390/cancers11111784. Cancers (Basel). 2019. PMID: 31766292 Free PMC article.
Resting energy expenditure in the risk assessment of anticancer treatments.
Jouinot A, Vazeille C, Durand JP, Huillard O, Boudou-Rouquette P, Coriat R, Chapron J, Neveux N, De Bandt JP, Alexandre J, Cynober L, Goldwasser F. Jouinot A, et al. Among authors: chapron j. Clin Nutr. 2018 Apr;37(2):558-565. doi: 10.1016/j.clnu.2017.01.007. Epub 2017 Jan 19. Clin Nutr. 2018. PMID: 28143668
The impact of body composition parameters on severe toxicity of nivolumab.
Hirsch L, Bellesoeur A, Boudou-Rouquette P, Arrondeau J, Thomas-Schoemann A, Kirchgesner J, Gervais C, Jouinot A, Chapron J, Giraud F, Wislez M, Alexandre J, Blanchet B, Goldwasser F. Hirsch L, et al. Among authors: chapron j. Eur J Cancer. 2020 Jan;124:170-177. doi: 10.1016/j.ejca.2019.11.003. Epub 2019 Nov 30. Eur J Cancer. 2020. PMID: 31794927
Octreotide treatment of idiopathic pulmonary fibrosis: a proof-of-concept study.
Crestani B, Chapron J, Wallaert B, Bergot E, Delaval P, Israel-Biet D, Lacronique J, Monnet I, Reynaud-Gaubert M, Tazi A, Lebtahi R, Debray MP, Brauner M, Dehoux M, Dornic Q, Aubier M, Mentré F, Duval X. Crestani B, et al. Among authors: chapron j. Eur Respir J. 2012 Mar;39(3):772-5. doi: 10.1183/09031936.00113011. Eur Respir J. 2012. PMID: 22379151 Free article. Clinical Trial. No abstract available.
48 results